Patents by Inventor Thomas Plitz

Thomas Plitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF REDUCING NEUROLOGICAL DAMAGE IN WILSON DISEASE PATIENTS
    Publication number: 20220387370
    Abstract: This disclosure generally relates to methods of treating copper-induced neurological damage observed in copper metabolism-associated diseases or disorders. This disclosure relates to reducing the copper-induced neurological damage in Wilson disease (WD).
    Type: Application
    Filed: November 20, 2020
    Publication date: December 8, 2022
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Thomas Plitz, Sabine Borchard, Hans Zischka
  • TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF RELAPSING MULTIPLE SCLEROSIS
    Publication number: 20100261887
    Abstract: The invention relates to TACI-Immunoglobulin fusion proteins for the treatment of relapsing multiple sclerosis.
    Type: Application
    Filed: November 11, 2008
    Publication date: October 14, 2010
    Applicant: Ares Trading S.A.
    Inventors: Alessandra Del Rio, Rinaldi Gianluca, Joel Richard, Thomas Plitz
  • TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS
    Publication number: 20100239580
    Abstract: The invention relates to TACI-Immunoglobulin fusion proteins for the treatment of optic neuritis.
    Type: Application
    Filed: November 10, 2008
    Publication date: September 23, 2010
    Applicant: Area Trading S.A.
    Inventors: Alessandra Del Rio, Gianluca Rinaldi, Joel Richard, Thomas Plitz